These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12604337)

  • 1. Merlin suppresses the SRE-dependent transcription by inhibiting the activation of Ras-ERK pathway.
    Lim JY; Kim H; Kim YH; Kim SW; Huh PW; Lee KH; Jeun SS; Rha HK; Kang JK
    Biochem Biophys Res Commun; 2003 Mar; 302(2):238-45. PubMed ID: 12604337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Phosphorylation status of merlin is important for regulating the Ras-ERK pathway.
    Jung JR; Kim H; Jeun SS; Lee JY; Koh EJ; Ji C
    Mol Cells; 2005 Oct; 20(2):196-200. PubMed ID: 16267393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of ras-mediated activator protein 1 activity and cell growth by merlin.
    Kim H; Lim JY; Kim YH; Kim H; Park SH; Lee KH; Han H; Jeun SS; Lee JH; Rha HK
    Mol Cells; 2002 Aug; 14(1):108-14. PubMed ID: 12243339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Merlin inhibits growth hormone-regulated Raf-ERKs pathways by binding to Grb2 protein.
    Lim JY; Kim H; Jeun SS; Kang SG; Lee KJ
    Biochem Biophys Res Commun; 2006 Feb; 340(4):1151-7. PubMed ID: 16405865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of NF-kappaB activation by merlin.
    Kim JY; Kim H; Jeun SS; Rha SJ; Kim YH; Ko YJ; Won J; Lee KH; Rha HK; Wang YP
    Biochem Biophys Res Commun; 2002 Sep; 296(5):1295-302. PubMed ID: 12207915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac.
    Morrison H; Sperka T; Manent J; Giovannini M; Ponta H; Herrlich P
    Cancer Res; 2007 Jan; 67(2):520-7. PubMed ID: 17234759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C/EBP beta and Elk-1 synergistically transactivate the c-fos serum response element.
    Hanlon M; Bundy LM; Sealy L
    BMC Cell Biol; 2000; 1():2. PubMed ID: 11151091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Merlin cooperates with neurofibromin and Spred1 to suppress the Ras-Erk pathway.
    Cui Y; Ma L; Schacke S; Yin JC; Hsueh YP; Jin H; Morrison H
    Hum Mol Genet; 2021 Feb; 29(23):3793-3806. PubMed ID: 33331896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells.
    Lowe WL; Fu R; Banko M
    Endocrinology; 1997 Jun; 138(6):2219-26. PubMed ID: 9165004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kinase suppressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk-1 phosphorylation from MAP kinase activation.
    Sugimoto T; Stewart S; Han M; Guan KL
    EMBO J; 1998 Mar; 17(6):1717-27. PubMed ID: 9501093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic increase in c-fos expression by simultaneous activation of the ras/raf/map kinase- and protein kinase A signaling pathways is mediated by the c-fos AP-1 and SRE sites.
    Seternes OM; Sørensen R; Johansen B; Loennechen T; Aarbakke J; Moens U
    Biochim Biophys Acta; 1998 Feb; 1395(3):345-60. PubMed ID: 9512670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAP, a protein interacting with a tumor suppressor, merlin, through the run domain.
    Lee IK; Kim KS; Kim H; Lee JY; Ryu CH; Chun HJ; Lee KU; Lim Y; Kim YH; Huh PW; Lee KH; Han SI; Jun TY; Rha HK
    Biochem Biophys Res Commun; 2004 Dec; 325(3):774-83. PubMed ID: 15541357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The merlin tumor suppressor interacts with Ral guanine nucleotide dissociation stimulator and inhibits its activity.
    Ryu CH; Kim SW; Lee KH; Lee JY; Kim H; Lee WK; Choi BH; Lim Y; Kim YH; Lee KH; Hwang TK; Jun TY; Rha HK
    Oncogene; 2005 Aug; 24(34):5355-64. PubMed ID: 16007223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clue to the therapy of neurofibromatosis type 2: NF2/merlin is a PAK1 inhibitor.
    Hirokawa Y; Tikoo A; Huynh J; Utermark T; Hanemann CO; Giovannini M; Xiao GH; Testa JR; Wood J; Maruta H
    Cancer J; 2004; 10(1):20-6. PubMed ID: 15000491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erbin regulates mitogen-activated protein (MAP) kinase activation and MAP kinase-dependent interactions between Merlin and adherens junction protein complexes in Schwann cells.
    Rangwala R; Banine F; Borg JP; Sherman LS
    J Biol Chem; 2005 Mar; 280(12):11790-7. PubMed ID: 15659388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms for somatostatin inhibition of c-fos gene expression.
    Todisco A; Takeuchi Y; Yamada J; Sadoshima JI; Yamada T
    Am J Physiol; 1997 Apr; 272(4 Pt 1):G721-6. PubMed ID: 9142901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of the relationship between the neurofibromatosis 2 tumor suppressor and its binding partner, hepatocyte growth factor-regulated tyrosine kinase substrate.
    Sun CX; Haipek C; Scoles DR; Pulst SM; Giovannini M; Komada M; Gutmann DH
    Hum Mol Genet; 2002 Dec; 11(25):3167-78. PubMed ID: 12444101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.
    Laulajainen M; Muranen T; Carpén O; Grönholm M
    Oncogene; 2008 May; 27(23):3233-43. PubMed ID: 18071304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori CagA protein activates serum response element-driven transcription independently of tyrosine phosphorylation.
    Hirata Y; Maeda S; Mitsuno Y; Tateishi K; Yanai A; Akanuma M; Yoshida H; Kawabe T; Shiratori Y; Omata M
    Gastroenterology; 2002 Dec; 123(6):1962-71. PubMed ID: 12454853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.